Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7042
Source ID: NCT01399645
Associated Drug: Liraglutide-Metformin Vs Insulin-Metformin
Title: Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
Acronym: LIRAINS
Status: COMPLETED
Study Results: NO
Results:
Conditions: Nonalcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis|Type 2 Diabetes
Interventions: DRUG: Liraglutide-metformin vs insulin-metformin
Outcome Measures: Primary: To determine liver fat fraction evolution induced by liraglutide and insulin, Improvement in liver steatosis defined by change in liver fat fraction as measured by MRI and MR spectroscopy at baseline and 12 weeks of treatment., 12 weeks |
Sponsor/Collaborators: Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Collaborators: Centre de Recherche du Centre Hospitalier de l'Université de Montréal|Diabetes Québec|Radiological Society of North America|Canadian Heads of Academic Radiology-GE Healthcare Development Award
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 35
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2011-05
Completion Date: 2014-06
Results First Posted:
Last Update Posted: 2014-08-27
Locations: Centre hospitalier de l'Université de Montréal, Montréal, Quebec, H2W 1T7, Canada
URL: https://clinicaltrials.gov/show/NCT01399645